Advertisement

Benign Hematological Diseases in Cancer Patients

  • Kelly N. Casteel
  • Michael H. Kroll
Reference work entry

Abstract

Cancer patients frequently develop hematological problems that require direct management. Understanding their pathophysiology provides one with important clinical insight that directs appropriate therapeutic interventions.

Keywords

Thrombocytopenia Neutropenia Anemia Coagulopathy Thrombosis Hypercoagulability 

References

  1. 1.
    Andersohn F, Konzen C, Garbe E. Systemic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146:657–65.CrossRefGoogle Scholar
  2. 2.
    Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–7.CrossRefGoogle Scholar
  3. 3.
    Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017;377:1177–87.CrossRefGoogle Scholar
  4. 4.
    Escobar MA. Bleeding in the patient with a malignancy: is it an acquired factor VIII inhibitor? Cancer. 2012;118:312–20.  https://doi.org/10.1002/cncr.26304.CrossRefPubMedGoogle Scholar
  5. 5.
    Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2012;11:223–33.CrossRefGoogle Scholar
  6. 6.
    Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematology. 2007;23:105–19.PubMedGoogle Scholar
  7. 7.
    Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142:348–60.CrossRefGoogle Scholar
  8. 8.
    Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the US population: age, sex, smoking status and ethnic differences. Ann Intern Med. 2007;146:486–92.CrossRefGoogle Scholar
  9. 9.
    Hsieh MM, Tisdale JF, Rodgers GP. Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol. 2010;28:1633–7.CrossRefGoogle Scholar
  10. 10.
    Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med. 2014;370:847–59.CrossRefGoogle Scholar
  11. 11.
    Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med.  https://doi.org/10.1016/j.amjmed.2003.12.008.
  12. 12.
    Laskin B, Goebel J, Davies S, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy. Blood. 2011;118:1452–62.  https://doi.org/10.1182/blood-2011-02-321315.CrossRefPubMedGoogle Scholar
  13. 13.
    Lebovic D. (2018) Anemia in Malignancy. In: Provenzano R., Lerma E., Szczech L. (eds) Management of Anemia. Springer, New York, NY.Google Scholar
  14. 14.
    Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131:845–54.CrossRefGoogle Scholar
  15. 15.
    Leyland-Jones B, Bondarenko I, Nemsadze G, et al. A randomized, open-label, multicenter, phase III study of Epoetin alfa versus best standard of care in anemic patients with metastatic breast cancer receiving standard chemotherapy. J Clin Oncol. 2016;34:1197–207.  https://doi.org/10.1200/JCO.2015.63.5649.CrossRefPubMedGoogle Scholar
  16. 16.
    Morton JM, George JN. Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer. J Oncol Pract. 2016;12:522–30.CrossRefGoogle Scholar
  17. 17.
    Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1:2295–301.CrossRefGoogle Scholar
  18. 18.
    Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev. 2009;23:105–11.CrossRefGoogle Scholar
  19. 19.
    Rodgers GM et al. Cancer- and chemotherapy-induced anemia. NCCN Clinical Practice Guidelines in Oncology Version 2.2018 – 11/21/2017. 2017.Google Scholar
  20. 20.
    Sanford RA, Kroll MH. Cancer-associated thrombosis. In: Kantarjian HM, Wolff RA, editors. The MD Anderson manual of medical oncology. 3rd ed. New York: McGraw-Hill; 2016.Google Scholar
  21. 21.
    Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018;36:283–99.CrossRefGoogle Scholar
  22. 22.
    Smith TJ, Bohlke K, Armitage JO. Recommendations for the use of white blood cell growth factors: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract. 2015;11:511–3.CrossRefGoogle Scholar
  23. 23.
    Tas F, Eralp Y, Basaran M, et al. Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol. 2002;25:371–9.CrossRefGoogle Scholar
  24. 24.
    Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110:1723–9.CrossRefGoogle Scholar
  25. 25.
    Gibson C, Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014;124(8):1251–8.  https://doi.org/10.1182/blood-2014-02-482612.
  26. 26.
    Mantha S et al. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood. 2017;129(13):1763–1767.  https://doi.org/10.1182/blood-2016-10-747170.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Kelly N. Casteel
    • 1
  • Michael H. Kroll
    • 1
  1. 1.UT MD Anderson Cancer CenterHoustonUSA

Personalised recommendations